Remove tag clinical-trials-1
article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

New technologies are being developed that allow for virtual clinical trials and other cost-lowering development costs. Hospitals receive $1 out of every $3 spent on health care, and the United States is projected to spend about $1.3 If pharma is a business, they will find a way to develop, buy, or acquire new drugs.

article thumbnail

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Pharmaceutical Technology

The US Food and Drug Administration (FDA) put a high-profile bluebird bio trial for sickle cell disease on partial clinical hold, and advisory panels deliberated over decisions involving gene therapies for amyotrophic lateral sclerosis (ALS), cerebral adrenoleukodystrophy (CALD), and beta-thalassemia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

High-prescribing physicians surveyed by GlobalData across eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) identified a broad range of unmet needs in the IO space (see Figure 1). Cost-related unmet needs also scored highly.

article thumbnail

CHMP backs J&J’s myeloma bispecific Tecvayli, ahead of US decision

pharmaphorum

J&J filed for approval of the bispecific in the US in December based on the results of the phase 1b MajesTEC-1 study in myeloma patients who had been treated with a median of five lines of prior therapy. Tecvayli previously scored a priority medicines (PRiME) designation from the EMA and a breakthrough-therapy tag from the FDA.

article thumbnail

Actualising the power of antibody-drug conjugates as cancer therapeutics

European Pharmaceutical Review

In total, there are 14 approved ADCs on the global market, all for oncology indications, and over 140 ADCs currently in clinical development. 1 While the first successes underscored the potential of this class of targeted therapies, they also revealed bottle?necks cancer agent or disease-relevant toxin. necks inhibiting these first?generation

article thumbnail

Don’t Wait—Uncover the Clinical Endpoints that Will Matter to Payers and HCPs

PM360

It’s never too early in the research and development (R&D) process to identify and measure a product’s projected clinical outcomes in order to meet the needs and expectations of payers and healthcare professionals (HCPs) who are the final arbiters of a product’s commercial success. million for the new hemophilia gene therapy.

article thumbnail

How to Become a Medical Sales Rep & Build a Successful Career As One

Map My Customers

Surgical Equipment Sales - This type of rep will be selling specialized surgery equipment that often comes with a high price tag. If you are a pharmaceutical sales rep, do your research on the background of the medications, stay up-to-date on the newest clinical trials, etc.